In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant

Journal of Clinical Investigation

Volumn 104, Issue 1, 1999, Pages 93-102

  Combes, Valéry ^a   Simon, Anne Christine ^a   Grau, Georges Emile ^a,b   Arnoux, Dominique ^b   Camoin, Laurence ^b   Sabatier, Florence ^b   Mutin, Murielle ^b   Sanmarco, Marielle ^b   Sampol, José ^a,b   Dignat George, Françoise ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LUPUS ANTICOAGULANT;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; THROMBOSIS;

EID: 0032694867     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4985     Document Type: Article

References (42)

1. Bombeli, T., Mueller, M., and Haeberli, A. 1997. Anticoagulant properties of the vascular endothelium. Thromb. Haemost. 77:408-423.
2. Rodgers, G.M. 1992. Hemostatic properties of normal and perturbed vascular cells. FASEB J. 2:116-125.
3. Crossman, D.C., Carr, D.P., Tuddenham, E.G., Pearson, D., and McVey, J.H. 1990. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J. Biol. Chem. 265:9782-9787.
4. Moore, K.L., Esmon, C.T., and Esmon, N.L. 1989. Tumor necrosis factor leads to internalisation and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood. 73:159-165.
5. Bevilacqua, M.P. 1993. Endothelial leukocyte adhesion molecules. Annu. Rev. Immunol. 11:767-804.
6. Zwaal, R.F.A., and Schroit, A.J. 1997. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 89:1121-1132.
7. Satta, N., et al. 1994. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J. Immunol. 153:3245-3255.
8. Pasquet, J.M., Toti, F., Nurden, A.T., and Dachary-Prigent, J. 1996. Procoagulant activity and active calpain in platelet-derived microparticles. Blood. 82:509-522.
9. Sims, P.J., Wiedmer, T., Esmon, C.T., Weiss, H.J., and Shattil, S.J. 1989. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J. Biol. Chem. 264:17049-17057.
10. Nieuwland, R., et al. 1997. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation. 96:3534-3541.
11. Gawaz, M., Neumann, F.J., Ott, I., Schiessler, A., and Sschömig, A. 1996. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation. 93:229-237.
12. Warkentin, E., et al. 1994. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 84:3691-3699.
13. Wiedmer, T., et al. 1993. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelet of paroxysmal nocturne hemoglobinuria. Blood. 82:1192-1196.
14. Hamilton, K.K., Hattori, R., Esmon, C.T., and Sims, P.J. 1990. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J. Biol. Chem. 5:3809-3814.
15. Brandt, J.T., Triplett, D.A., Alving, B., and Scharrer, I. 1995. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb. Haemost. 74:1185-1190.
16. Mutin, M., George, F., Lesaule, G., and Sampol, J. 1996. Reevaluation of trypsin-EDTA for endothelial cell detachment before flow cytometry analysis. Endothelium. 4:289-295.
17. Combes, V., Dignat-George, F., Mutin, M., and Sampol, J. 1997. A new flow cytometry method of platelet-derived microvesicle quantification in plasma. Thromb. Haemost. 77:220 [letter].
18. Jy, W., Horstman, L.L., Arce, M., and Ahn, Y.S. 1992. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J. Lab. Clin. Med. 119:334-345.
19. Jy, W., Mao, W.W., Horstman, L.L., Tao, J., and Ahn, Y.S. 1995. Platelet mieroparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol. Dis. 30:217-231.
20. Holme, P.A., et al. 1996. Glycoprotein IIb-IIIa on platelet-derived microparticles structures studied by electron microscopy, confocal laser microscopy and crossed radio-immunoelectrophoresis. Platelets. 7:207-214.
21. Nawroth, P.P., and Stern, D.M. 1986. Modulation of endothelial cells by TNF haemostatic properties. J. Exp. Med. 163:740-756.
22. Slowik, M.R., et al. 1997. Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. Lab. Invest. 77:257-267.
23. Abrams, C.S., Ellison, N., Budzynski, A.Z., and Shattil, S.J. 1990. Direct detection of activated platelets and platelets-derived microparticles in humans. Blood. 1:128-138.
24. Mesri, M., and Altieri, D.C. 1998. Endothelial cell activation by leukocyte microparticles. J. Immunol. 161:4382-4387.
25. Barry, O.P., Pratico, D., Savani, R.C., and FitzGerald, G.A. 1998. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J. Clin. Invest. 102:136-144.
26. Holme, P.A., Solum, N.O., Brosstad, F., Pedersen, T., and Kveine, M. 1998. Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets. Thromb. Haemost. 79:389-394.
27. Gawaz, M., et al. 1997. Vitronectin receptor (αvβ3) mediates platelet adhesion to the luminal aspect of endothelial cells. Circulation. 96:1809-1818.
28. Bevilacqua, M.E., et al. 1991. Selectins: a family of adhesion receptors. Cell. 67:233 [letter].
29. Mutin, M., Dignat-George, F., and Sampol, J. 1997. Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules. Tissue Antigens. 50:449-458.
30. Poujol, C., Nurden, A.T., and Nurden, P. 1997. Ultrastructural analysis of the distribution of the vitronectin receptor (αvβ3) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the α-granule membrane. Br. J. Haematol. 97:823-835.
31. Harris, E.N., Pierangeli, S.S., and Gharavi, A.E. 1998. Diagnosis of the antiphospholipid syndrome: a proposal for use of laboratory tests. Lupus. 7 (Suppl. 2):S144-S148.
32. Wahl, D.G., et al. 1997. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus: a meta-analysis. Lupus. 6:467-473.
33. Arnout, J. 1996. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb. Haemost. 75:536-541.
34. Lellouche, F., Martinuzzo, M., Said, P., Maclouf, J., and Carreras, L.O. 1991. Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood. 78:2894-2899.
35. Oosting, J.D., et al. 1993. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood. 81:2618-2625.
36. Shibata, S., Harpel, P.C., Gharavi, A., Rand, J., and Fillit, H. 1994. Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood. 83:2532-2540.
37. Tsakiris, D.A., Marbet, G.A., Makris, P.E., Settas, L., and Duckert, F. 1989. Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant. Thromb. Haemost. 61:175-177.
38. Simanrov, R., et al. 1995. Activation of cultured vascular endothelial cells by endothelial antibodies. J. Clin. Invest. 96:2211-2219.
39. Rand, J.H. 1998. Antiphospholipid antibody syndrome: new insights on thrombogenic mechanisms. Am. J. Med. Sci. 16:142-151.
40. Branch, D.W., and Rodgers, G.M. 1993. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. Am. J. Obstet. Gynecol. 168:206-210.
41. Amengual, O., Atsumi, T., Khamashta, M.A., Koike, T., and Hughes, G.R.V. 1996. Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome. Br. J. Rheumatol. 35:1239-1243.
42. Oosting, J.D., Derksen, R.H., Blokzijl, L., Sixma, J.J., and de Groot, P.G. 1992. Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity studies in a thrombosis model. Thromb. Haemost. 68:278-284.